We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zoll Licenses Software for AEDs from Research Center

By HospiMedica staff writers
Posted on 08 Sep 2004
In order to enhance its future defibrillator products, Zoll Medical Corp. More...
(Chelmsford, MA, USA) has obtained an exclusive license for new software from the Institute of Critical Care Medicine (ICCM, Palm Springs, CA, USA) that will improve the accuracy of administering cardiopulmonary resuscitation (CPR) and defibrillation in victims of sudden cardiac arrest (SCA).

The new software will be integrated into Zoll's automated external defibrillator (AED PLUS), where it can determine whether CPR should be performed before defibrillation. The software has also been shown to predict successful defibrillation with a likelihood exceeding 90% accuracy. Improving the delivery of these early therapies might be able to increase the survival rates of SCA, currently a low 5%.

"This software development further advances the Institute's goal of expanding AEDs to become intelligent ‘resuscitation boxes,' which can provide even untrained rescuers with valuable prompting of how, and when, to perform CPR and/or defibrillation,” noted Max Harry Weil, M.D., co-inventor of the software and president of the institute. The ICCM is an international nonprofit research center.

There are more than 460,000 cases of cardiac arrest each year in the United States alone.





Related Links:
Zoll
ICCM

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.